SRF and cancer: For example, IGF2BP1 and IGF2BP2 have a shared consensus GG(m6A)C binding sequence [58], though in adult cancer cells, the binding of IGF2BP1 and not IGF2BP2 results in the protection of some oncogenic transcripts (e.g., SRF) from miRNA-directed transcript downregulation [156].